Clomid Alternatives: What Replaces It for Women, and for Men
Clomid Alternatives: What Replaces It for Women, and for Men
Clomid alternatives exist because Clomid fails in a predictable set of situations: about one woman in five does not ovulate on it, most who ovulate do not conceive in any given cycle, its anti-estrogen effect thins the lining in some women, it produces more twins than its nearest competitor, and in men it is off-label with side effects some cannot tolerate. For each failure there is a next step with trial evidence behind it. In women with polycystic ovary syndrome the first alternative has become the first choice: letrozole produced more live births than Clomid in the largest trial run. For men the alternatives are a different isomer of the same molecule, an injection that mimics LH, and testosterone itself.
This page lists the alternatives by the problem they solve, with the trial figures, and says which have evidence and which are marketing. The Clomid for women and Clomid for low testosterone guides cover Clomid itself.
Key takeaway: for anovulation, letrozole is the main alternative and beat Clomid on live birth (27.5% vs 19.1%) and twins (3.4% vs 7.4%) in PCOS; metformin helps PCOS alongside Clomid but not alone; gonadotropins and IVF are the next tier. For men, enclomiphene, hCG and anastrozole each replace Clomid for a specific reason, and testosterone replacement is the alternative that gives up fertility. "Natural Clomid" supplements are not alternatives.
Alternatives for Women, by Problem
Clomid alternatives for ovulation induction
Letrozole (Femara)
First line in PCOS; Clomid resistance; thin endometrium on Clomid
Legro 2014, NEJM, 750 women: live birth 27.5% vs 19.1%, ovulation 61.7% vs 48.3% of cycles, twins 3.4% vs 7.4%
Metformin
Added to Clomid in PCOS with insulin resistance; rarely alone
Legro 2007, NEJM, 626 women: live birth 22.5% Clomid, 7.2% metformin, 26.8% combination
Gonadotropin injections (FSH, hMG)
Second line after Clomid or letrozole fail
Cochrane 2025 review of 15 trials, 2,348 women with PCOS: higher ovulation and pregnancy, with more monitoring and higher multiple-pregnancy risk
Tamoxifen
Occasional substitute SERM when Clomid is not tolerated
Small trials; similar ovulation rates; not approved for this use
Laparoscopic ovarian drilling
Clomid-resistant PCOS where injections are not wanted
Surgical option; comparable live-birth rates to gonadotropins in trials
IUI and IVF
Other factors present: tubal, male, unexplained infertility, age
Standard assisted reproduction; the step after oral agents
Letrozole: The Alternative That Became First Line
Letrozole is an aromatase inhibitor developed for breast cancer; it induces ovulation by lowering estrogen for a few days so the pituitary raises FSH, the same end result as Clomid by a different route, and because it clears quickly it does not leave an anti-estrogen effect on the lining or the cervix. In the 2014 trial of 750 women with PCOS, cumulative live birth was 27.5% on letrozole against 19.1% on Clomid, ovulation occurred in 61.7% of letrozole cycles against 48.3%, and twin pregnancy was 3.4% against 7.4%, with no significant difference in pregnancy loss or anomalies. Letrozole is prescribed off-label for ovulation induction in the US; the full comparison, including the women for whom Clomid still makes sense, is in Clomid vs letrozole.
Metformin, Gonadotropins and Beyond
Metformin on its own is a poor substitute: 7.2% live birth against 22.5% for Clomid in the 2007 trial. Combined with Clomid it reached 26.8%, not significantly better than Clomid alone, so it is an addition for women with PCOS and insulin resistance rather than an alternative. Gonadotropin injections bypass the pituitary and stimulate the ovary directly, which is why they work when Clomid and letrozole do not and why they need ultrasound monitoring: the Cochrane 2025 review of second-line treatment in PCOS confirms higher ovulation and pregnancy rates and a higher multiple-pregnancy risk that the monitoring exists to contain. IVF is the alternative when ovulation was never the only problem, which the success rate guide explains is the case in unexplained and tubal infertility.
Alternatives for Men
Clomid alternatives for low testosterone in men
Enclomiphene
The active isomer alone; less of the estrogenic zuclomiphene that accumulates on Clomid; fewer mood and visual complaints reported
Compounded only in the US; not FDA-approved
hCG injections
Acts directly on the testes; works when the pituitary cannot respond; preserves fertility
Injections two to three times a week; cost
Anastrozole
Lowers estrogen to raise testosterone; suits men with high estradiol or a high estradiol-to-testosterone ratio
Bone-density concern with long use; off-label
Testosterone replacement
Raises testosterone directly and reliably
Shuts down sperm production and natural testosterone; a treatment for life
Enclomiphene is the alternative most men asking the question are looking for, and the site's enclomiphene vs Clomid guide covers the isomer difference and the evidence. Testosterone replacement is the alternative that resolves symptoms most predictably and costs fertility and the hypothalamic axis in return, which is why Clomid is tried first in men who want children. For men recovering after anabolic steroid use, the PCT guide covers what the evidence says about any of these agents, which a 2026 Society for Endocrinology position statement summarised as limited and low quality, with most men recovering on their own within about a year.
What Is Not an Alternative
"Natural Clomid" and "Clomid alternative" supplements are herbal blends, vitex, maca, tribulus, D-aspartic acid, with no clomiphene and no trial showing ovulation induction or a clinically meaningful testosterone rise. They are sold because the phrase has search volume, not because they do what Clomid does. Research chemicals sold as "clomiphene" or "enclomiphene" online are the other non-alternative: the same molecule, with no verification of dose or purity and no prescriber, which is the subject of how to get Clomid.
Frequently Asked Questions
For women with PCOS, letrozole: 27.5% live birth versus 19.1% and half the twin rate in the 2014 NEJM trial. For men who want to keep fertility, enclomiphene or hCG.
In PCOS, yes on live birth, ovulation and twin rate. For other causes of anovulation the evidence is thinner and Clomid remains an option.
No supplement induces ovulation or raises testosterone the way clomiphene does. Weight loss in overweight women with PCOS is the one non-drug measure with evidence.
Letrozole first, metformin added in PCOS with insulin resistance, then gonadotropin injections, ovarian drilling or IVF depending on the cause.
Enclomiphene (the active isomer), hCG injections, anastrozole for men with high estradiol, or testosterone replacement for men who do not need fertility.
Some clinics use them together in resistant cases, but it is not a standard protocol and the trials compared them head to head, not combined.
Clomid.org is an independent educational resource. We are not affiliated with any pharmaceutical manufacturer, compounding pharmacy, telehealth company or healthcare provider. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.
Daniel Okafor
Author
Comments (0)
Be the first to comment on this article.


